Laserfiche WebLink
training and education of the Substance Abuse Professional must meet or exceed 40 CFR <br /> Part 40, Subpart O. <br /> MEDICAL REVIEW OFFICER(MRO) <br /> The designated MRO shall be a licensed physician with knowledge of drug disorders. <br /> SRA uses the following MRO: <br /> Dr.Natalie Hartenbaum <br /> c/o First Lab <br /> 1364 Welsh Road, Suite C-2 <br /> North Wales,PA 19454- 1913 <br /> Phone: 800-732-3784 <br /> Fax: 215-641-4959 <br /> www.firstlab.com <br /> DOT Acct#09545680 <br /> FL DFWP Acct#37198025 <br /> The role of the MRO is to review, interpret and confirm test results,and examine alternate <br /> medical explanation for positive test results by conducting further medical interviews and <br /> review of the individual's medical history or other relevant factors. The MRO shall review all <br /> medical records made available by the tested individual when a confirmed positive test could <br /> have resulted from a legally prescribed medication. The MRO shall not consider results of <br /> urine samples that are not obtained or processed in accordance to DOT regulations. <br /> The MRO shall report to a designee of SRA using any written communication reporting <br /> device on test results,two (2)business days following the completion of a test. <br /> The report will contain: <br /> ❑ Full name of the employee tested,as indicated on the Custody& Control Form <br /> ❑ Specimen ID from the CCF; donor SSN, or employee ID number <br /> ❑ Date of collection <br /> ❑ Date MRO received copy of the CCF <br /> ❑ Result of test;date test was verified <br /> An employee shall be notified by the MRO of a laboratory confirmed positive test and a <br /> verification interview will be conducted with the employee by the MRO, in accordance <br /> with 49 CFR Parts 40.131,through 40.141. <br /> Random Program Compliance <br /> • First Lab will send a monthly/quarterly reminder when an update of the client employee <br /> list is due. <br /> • SRA will monitor testing numbers throughout the year and make adjustments as needed <br /> to each selection period to keep on track. <br /> • An alternative report option will be provided for the selection of alternates if there is an <br /> employee selected who is not available for testing in the selection period. <br /> • A Compliance Report will be generated so that the compliance status can be reviewed at <br /> any time. <br /> • An analysis will be completed before the last selection for the year to make sure that <br /> enough employees have been selected to ensure compliance for the year. <br /> 133 <br />